L.5. Safety of officers in dismantling illicit synthetic opioid laboratories OP 2 (c) (…) China: We would like to delete the wording from ‘exposure’ to ‘chemicals’. United States: WE would like to remain faithful to the intention of sponsors, which is in line with our policy. This resolution is for all member states but some …
Australia
Plenary — Wednesday morning session
Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it …
Committee of the Whole — Monday afternoon session
L.2. Promoting comprehensive, scientific evidence-based and multisectoral national systems of drug use prevention for children Chair: Welcome to the first CoW for the 68th CND session. This committee will have eight meetings, starting this afternoon through to Friday morning. We will suspend our work on Wednesday morning when voting in-person on agenda number 5. A …
Item 3. General Debate (Cont.)
Item 3. General Debate (Cont.) Iran. I wish to congratulate you for your election. I wish to thank the executive director for organizing this. The global issue of narcotic drugs is undergoing big issues. We are witnessing the emergence of NPS that have challenged monitoring and controlling systems. In order to have a more effective …
CND Intersessional – Session 6 – Other Substantial Matters
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Other Substantial Matters proposed by Member States • Challenges to the identification of new illicit drugs: Discussion on strategies and approaches by laboratories to enhance the capacity of forensic personnel and harnessing technology to improve identification methods …
CND Intersessional – Session 5 – Legal, Scientific, and Regulatory Challenges in Scheduling Substances
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Good Morning. Secretariat: (organizational matters + scheduling 101) Moderator/intro: Mr. Justice Tettey, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC: Good morning, dear colleagues. Thank you for this opportunity to address the question you posed about …